UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...

(Reuters) -The U.S. Food and Drug Administration told staff this week it cannot guarantee work space or parking spots among ...

Get a comprehensive overview of personal loan requirements. Understand the essentials to help you prepare for a successful ...

Learn about the Microsoft Security Response Center, which investigates vulnerabilities and releases security updates to help protect customers from cyberthreats.

Compound Semiconductor™ is an Angel Business Communications publication.